Skip to Main Content

Paper Details

Moving toward a contemporary classification of drug-induced kidney disease.
Crit Care
1
2023
AKI, DIKD, Drug-induced kidney disease, acute kidney injury, drug, kidney disease, patient, patients
Acute Kidney Injury, Biomarkers, Consensus, Critical Illness, Drug-Related Side Effects and Adverse Reactions, Humans
Author NameAffiliation
Iman KarimzadehSchool of Pharmacy, Shiraz University of Medical Sciences
Erin F BarretoDepartment of Pharmacy, Mayo Clinic
John A KellumCenter for Critical Care Nephrology, University of Pittsburgh School of Medicine
Linda AwdishuDivision of Clinical Pharmacy, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Patrick T MurrayUniversity College Dublin
Marlies OstermannKing's College London, Guy's and St Thomas' Hospital
Azra BihoracUniversity of Florida
Azra BihoracUniversity of Florida
Azra BihoracUniversity of Florida
Azra BihoracUniversity of Florida
Ravindra L MehtaUniversity of California
Stuart L GoldsteinCenter for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center
Kianoush B KashaniMayo Clinic
Sandra L Kane-GillCenter for Critical Care Nephrology, University of Pittsburgh School of Medicine
Sandra L Kane-GillDepartment of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh
Sandra L Kane-GillDepartment of Pharmacy
Sandra L Kane-GillSchool of Medicine and the Clinical Translational Science Institute, University of Pittsburgh
  • 1 - 17

Datasets